Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 15 full-time employees. The company went IPO on 2018-02-14. The company has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.
Follow-Up Questions
Motus GI Holdings Inc (MOTS) 的本益比是多少?
Motus GI Holdings Inc 的本益比是 0
Motus GI Holdings Inc 的 CEO 是誰?
Mr. Mark Pomeranz 是 Motus GI Holdings Inc 的 President,自 2016 加入公司。
MOTS 股票的價格表現如何?
MOTS 的當前價格為 $0,在上個交易日 decreased 了 0%。
Motus GI Holdings Inc 的主要業務主題或行業是什麼?
Motus GI Holdings Inc 屬於 Health Care 行業,該板塊是 Health Care
Motus GI Holdings Inc 的市值是多少?
Motus GI Holdings Inc 的當前市值是 $6.39
Motus GI Holdings Inc 是買入、賣出還是持有?
據華爾街分析師稱,共有 3 位分析師對 Motus GI Holdings Inc 進行了分析師評級,包括 2 位強烈買入,4 位買入,1 位持有,0 位賣出,以及 2 位強烈賣出